CYVADIC protocol
(NJFOMAJOQRLUNU-KWNLXFAZSA-N)
Structure
- SMILES
- CN(/N=N/c1nc[nH]c1C(=O)N)C.OCC(=O)[C@@]1(O)C[C@H](O[C@H]2C[C@H](N)[C@@H]([C@@H](O2)C)O)c2c(C1)c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2OC.O=CN1c2c(OC)c(ccc2[C@]23[C@@H]1[C@@](O)(C(=O)OC)[C@H](OC(=O)C)[C@]1([C@@H]3N(CC2)CC=C1)CC)[C@]1(C[C@H]2CN(CCc3c1[nH]c1c3cccc1)C[C@](C2)(O)CC)C(=O)OC.ClCCN(P1(=O)NCCCO1)CCCl
- Molecular Formula:
- C86H110Cl2N13O24P
- Molecular Weight:
- 1811.750
- Log P:
- 7.7778
- Hydrogen Bond Acceptor:
- 35
- Hydrogen Bond Donor:
- 12
- TPSA:
- 528.35
- CAS Number(s):
- N/A
Synonym(s)
1.
CYVADIC protocol
2.
CYVADACT
3.
CYVADIC
External Link(s)
Adverse Drug Event(s)
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.